Micronucleus testing as a cancer detector: endometrial hyperplasia to carcinoma
Purpose Endometrium carcinoma (EC) is the fourth common cancer among women worldwide and the incidence is increasing. It is important to define the EC earlier for survival of the patients. Methods Women who had endometrial hyperplasia (EH) and EC in postmenopausal and premenopausal period were inclu...
Gespeichert in:
Veröffentlicht in: | Archives of gynecology and obstetrics 2016-05, Vol.293 (5), p.1065-1071 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
Endometrium carcinoma (EC) is the fourth common cancer among women worldwide and the incidence is increasing. It is important to define the EC earlier for survival of the patients.
Methods
Women who had endometrial hyperplasia (EH) and EC in postmenopausal and premenopausal period were included to participate in this study. MN assay has been performed to participants for detection of the genetic damages and DNA instability.
Results
MN ratio was significantly higher in EC group compared to other two groups (EH and control groups) (
p
0.05). MN frequency and NDI were significantly correlated with the age in endometrial hyperplasia without atypia, endometrial cancer and control groups (
r
0.546,
p
|
---|---|
ISSN: | 0932-0067 1432-0711 |
DOI: | 10.1007/s00404-015-3867-y |